Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Feldt-Rasmussen

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
Stress (Amsterdam, Netherlands)|June 1, 2024
Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?Ditte H Rotvig, Anders Jorgensen, Johan Høy Jensen, et al.
Elife|April 6, 2021
Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trialDimitrios Chantzichristos, Per-Arne Svensson, Terence Garner, et al.
Thyroid : Official Journal of the American Thyroid Association|November 5, 2016
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Founder Effect of the RET<sup>C611Y</sup> Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
ESC Heart Failure|February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysisChristoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Plos One|February 4, 2022
Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphismsPradeesh Sivapalan, Stina Willemoes Borresen, Josefin Eklöf, et al.
Endocrinologia, Diabetes Y Nutricion|August 22, 2018
Adaptation and cross-cultural validation of the Spanish version of the Thyroid-Related Quality-of-Life Patient-Reported Outcome questionnaireMauro Boronat, Ana González-Lleó, Carlos Rodríguez-Pérez, et al.
Scientific Reports|June 24, 2021
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patientsSofie Bliddal, Karina Banasik, Ole Birger Pedersen, et al.
Orphanet Journal of Rare Diseases|April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trialRaphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Trials|June 21, 2013
Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trialTorquil Watt, Per Cramon, Jakob Bue Bjorner, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Stress (Amsterdam, Netherlands)|June 1, 2024
Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?Ditte H Rotvig, Anders Jorgensen, Johan Høy Jensen, et al.
Elife|April 6, 2021
Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trialDimitrios Chantzichristos, Per-Arne Svensson, Terence Garner, et al.
Thyroid : Official Journal of the American Thyroid Association|November 5, 2016
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Founder Effect of the RET<sup>C611Y</sup> Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
ESC Heart Failure|February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysisChristoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Plos One|February 4, 2022
Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphismsPradeesh Sivapalan, Stina Willemoes Borresen, Josefin Eklöf, et al.
Endocrinologia, Diabetes Y Nutricion|August 22, 2018
Adaptation and cross-cultural validation of the Spanish version of the Thyroid-Related Quality-of-Life Patient-Reported Outcome questionnaireMauro Boronat, Ana González-Lleó, Carlos Rodríguez-Pérez, et al.
Scientific Reports|June 24, 2021
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patientsSofie Bliddal, Karina Banasik, Ole Birger Pedersen, et al.
Orphanet Journal of Rare Diseases|April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trialRaphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Trials|June 21, 2013
Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trialTorquil Watt, Per Cramon, Jakob Bue Bjorner, et al.
Pageof 35